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Abstract
Background Protease-activated receptors (PARs), a
family member of G-protein coupled receptors, are
present and functionally active in a wide variety of
cells. The object of this study was to demonstrate the
presence and function of PAR-1 and PAR-2 in the
dorsal motor nucleus of the vagus (DMV). Methods
DMNV neurons were isolated from neonatal rat
brainstems using micro-dissection and enzymatic
digestion. Neurons were cultured in Neurobasal med-
ium A containing 2% B27 supplement. Intracellular
calcium concentration ([Ca2 + ]i) was measured using
fura-2 based microspectrometry. Expression of PARs
was detected by RT-PCR and immunofluorescent
staining. Key Result Thrombin and PAR-1 agonist
peptide activate PAR-1 with a maximum change in
[Ca2 + ]i expressed as DF/F0 of 229 ± 14% and
137 ± 7%, respectively. Trypsin and PAR-2 agonist
peptide activate PAR-2 with a maximum DF/F0
change of 258 ± 12% and 242 ± 10%, respectively.
Inhibition of phospholipase C (PLC) by U73312 (1 lm)
decreased the maximal change in DF/F0 induced by
PAR-1 activation from 140 ± 17% to 21 ± 3%, while
the PAR-2-mediated maximal change in DF/F0 de-
creased from 185 ± 21% to 19 ± 6%. Blockade of IP3
receptor with 2APB inhibited the maximal change in
DF/F0 due to PAR-1 and PAR-2 activation by 72 ± 13%
and 71 ± 20% respectively. PAR-1 immnuoreactivity
was present in DMV neurons. Increase in transcripts
for PAR-1 and PAR-2 were detected in DMV tissues
derived from IBD rats relative to control animals.
Conclusions & Inferences Our results indicate that
PAR-1 and PAR-2 are present in the DMV neurons,
and their activation leads to increases in intracellular
calcium via signal transduction mechanism that in-
volves activation of PLC and the production of IP3.
Keywords inflammatory bowel disease, inositol 1,4,5-
trisphosphate, intracellular calcium signalling,
phospholipase C, protease-activated receptors, the
dorsal motor nucleus of the vagus.
INTRODUCTION
Inflammatory bowel diseases (IBD), including ulcera-
tive colitis and Crohns disease, are major public health
problems in the United States. Although gastrointes-
tinal dysfunction complicates the management of IBD,
relatively little is known of the underlying mecha-
nisms. Disruption in the structure and function of the
intrinsic enteric nervous system has been described.1
Extrinsic nerves, mainly from the dorsal motor nucleus
of the vagus (DMV), provide innervation to the gastro-
intestinal tract and control almost every aspect of the
gastrointestinal functions. Little is known of the role
of the extrinsic nervous system in the development of
gastrointestinal dysfunction associated with the IBD.
The dorsal vagal complex consists of three compo-
nents: DMV, the nucleus of the solitary tract (NST) and
area postrema (AP). Area postrema borders the fourth
ventricle and senses chemical changes in the blood and
cerebrospinal fluid. The nucleus of the solitary tract
receives gastrointestinal stimuli through primary vagal
afferents. Dorsal motor nucleus of the vagus integrates
both peripheral and central signals from several differ-
ent sources including from the AP and afferent neurons
of the visceral organs, either directly or via interneu-
rons in NST.2 Dorsal motor nucleus of the vagus
neurons provide parasympathetic efferents to the gas-
trointestinal system to influence gastrointestinal activ-
ities such as swallowing, gut responses to distension
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and acidity, absorption of nutrient composition and
gallbladder contraction.3,4
Synthesis of inflammatory mediators occurs in the
enteric nervous system and in immune cells of the
gut-associated lymphoid tissue. These inflammatory
mediators, including cytokines, thrombin and trypsin,
are potentially important in the development of
IBD-induced gastrointestinal dysfunction. Protease-
activated receptors (PARs) are members of a G-protein-
coupled family of receptors. Protease-activated receptors
have been related to cellular responses to injury and
inflammation.5 Protease-activated receptors are
activated through a unique mechanism that involves
proteolytic cleavage of the extracellular N-terminal
domain, exposing a new N-terminus that acts as a
tethered ligand, binding and activating the receptor
itself. Four different PARs have been cloned. Protease-
activated receptor 1 and PAR-3 are activated by throm-
bin, while PAR-2 is activated by trypsin and mast cell
tryptase, and PAR-4 is activated by both trypsin and
thrombin.6–9Protease-activatedreceptorsarepresentina
variety of tissues and cell types, including the CNS and
the enteric nervous system.10–12 Whether PARs are
present in the DMV is currently unknown.
Previous studies have shown that the DMV may
respond to systemic endotoxin,13 suggesting that the
DMV may possess the characteristics of a circumven-
tricular organ with a highly permeable blood–brain
barrier.14–16 Furthermore, the permeability of the
blood-brain barrier has been reported to be increased
by TNBS-induced colitis in both rats and rabbits.17,18
Our previous studies demonstrated the structural and
functional alterations of DMV neurons in response to
pro-inflammatory cytokines in the setting of intestinal
inflammation.19 In this study, we investigate the
presence of PAR-1 and PAR-2 in DMV neurons, and
to elucidate the cellular mechanisms that are triggered
upon PAR activation. We report here that PAR-1 and
PAR-2 are expressed and are functionally active in
cultured DMV neurons of the rat. The current study
demonstrates the existence of receptor-specific signal
transduction mechanisms that involve activation of
phospholipase C (PLC) and inositol 1,4,5-trisphosphate
(IP3) following PAR occupation in DMV neurons.
MATERIALS AND METHODS
Chemicals and solutions
Neurobasal medium A, phosphate buffer solution (PBS), B27
supplement, L-glutamine, penicillin and streptomycin were
purchased from Gibco (Grand Island, NY, USA). b fibroblast
growth factor (bFGF) was from Invitrogen (Carlsbad, CA, USA).
Poly-D-lysine, Triton X-100, thrombin, collagenase type V and
2,4,6-trinitrobenzene sulphonic acid (TNBS) were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Trypsin was purchased from
Worthington Biochemicals (Lakewood, NJ, USA). U-73343 and U-
73122 were from RBI (Natick, MA, USA). Fura-2 acetoxymethyl
ester and fura-2 free acid were purchased from Molecular Probes
(Eugene, OR, USA). Protease-activated receptor peptides (PARP-1
and PARP-2) were purchased from Peptides International (Louis-
ville, KY, USA).
DMV cell culture
Dorsal motor nucleus of the vagus neurons were isolated from 2
to 5 days old Sprague–Dawley rats as previously described.20
Neonatal rats were euthanized by decapitation. The brainstem
was rapidly removed and chilled at 0 C in a dissection solution
containing: NaCl 138 mmol L)1, KCl 4 mmol L)1, MgCl2
1 mmol L)1, CaCl2 2 mmol L
)1, glucose 20 mmol L)1, HEPES
10 mmol L)1. Tissue blocks were prepared and sectioned trans-
versely into 400 lm slices at the level of the obex using a
Vibratome 3000 (Redding, CA, USA). The DMV area was identified
under a dissecting microscope as the area immediately ventral to
the nuclei of the solitary tract and dorsal to the XII nuclei. Dorsal
motor nucleus of the vagus tissue was excised and then digested in
an enzyme solution containing protease type XIV (0.6 mg mL)1)
and trypsin type I (0.4 mg mL)1) at 32 C for 30–60 min. The tissue
was then dissociated by gentle trituration with pipettes. Cells
were plated onto poly-D-lysine coated 25 mm slides in 35 mm
culture dishes. Neurons were maintained at 37 C in an
atmosphere of 5% CO2 in serum-free culture media containing
Neurobasal medium A containing 2% B27 supplement,
2 mmol L)1 glutamine, 1% penicillin and streptomycin, and
5 ng mL)1 bFGF. After 4 days, one-half of the medium was
replaced and experiments were conducted at 7 days. NTS neurons
which typically are smaller and demonstrate a smaller membrane
capacity in whole cell patch clamping were excluded. This
protocol used to isolate and culture DMV neurons from neonatal
rats was approved by the University of Michigan Committee on
Use and Care of Animals.
[Ca2+]i measurement
Four lmol mL)1 of the fura-2-AM was added to cultured DMV
neurons in fresh warm serum-free growth media and incubated at
37 C for 30 min prior to experimentation. Cells were washed and
maintained in HBSS. Coverslips were then placed in a perfusion
chamber mounted on the stage of a Nikon inverted fluorescence
microscope (Mager Scientific Inc., Dexter, MI, USA). The rate of
superfusion of buffer and reagents was kept constant at
1 mL min)1. For Ca2+-free conditions, HBSS without CaCl2 was
used.
A Nikon inverted microscope with a · 40 oil immersion
objective and TILLvision digital imaging system (TILL Photonics,
Pleasanton, CA, USA) were used. Single-cell cytoplasmic calcium
([Ca2+]i) was determined from the ratio of fluorescence intensity of
fura-2-AM at 340 and 380 nm, monitored by an intensified charge-
couple device camera, and subsequently digitized. Background
intensity at each emission wavelength was corrected. The ratio of
fluorescence intensities at 340 and 380 nm was plotted as the
change in fluorescence (DF/F0), expressed as a percentage of the
basal fluorescence ratio observed in the absence of stimulus. Cells
were considered responsive if maximal DF/F0 increment was equal
to or greater than 15% above the baseline for each experimental
condition. Coverslips were superfused with KCl (55 mmol L)1) at
the end of each experiment, and cells were excluded if intracel-
lular Ca2+ did not increase.
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RT-PCR
Total RNA was isolated from rat DMV tissues. Single-strand
cDNA synthesis was performed as follows: 30 lL of reverse
transcription mixture contained 1 lg of DNase I pre-treated total
RNA, 0.75 lg of oligo d(T) primer, 6 lL of 5x RT buffer,
10 mmol L)1 dithiothreitol, 0.5 mmol L)1 deoxynucleotides, 50
units of RNase inhibitor, and 240 units of reverse transcriptase
(Invitrogen). The RT reaction was carried out at 40 C for 70 min
followed by heat inactivation at 95 C for 3 min. PCR primers
were deduced from published rat sequences. PCR was performed
in a total 25 lL volume, containing 2.5 lL cDNA, 5 mmol L)1
MgCl2, 0.2 mmol L
)1 dNTPs, 0.25 lmol L)1 each primer, 1.25 U
Ampli Taq Polymerase (Roche Diagnostics, Indianapolis, IN,
USA). The PCR program was: hold 95 C for 5 min; 95 C for 15 s,
60 C for 30 s, and 72 C for 1 min. Melt curve analysis was from
60 C to 95 C at 0.2 C/second with Optics Ch1 On. PCR
products were also visualized by 1.5% agarose gel electrophoresis.
The PCR bands were isolated from the gel, sequenced, and
confirmed with known sequences. mRNA expression was quan-
tified using the comparative cross threshold (CT) method. The CT
value of the housekeeping gene glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was subtracted from the CT value of
the target gene to obtain DCT. The normalized fold changes of
PARs mRNA expression were expressed as 2-DDCT, where DDCT
equals to DCT sample)DCT control.
The primers used for PCR were as follows:
PAR1 (access number M81642.1) Sense: 259-AGGGGATGA
GGAGGAGAAAA-278
Antisense: 451-CAGGGGAAGGCTGACTATGA-432




Animal studies were approved by the University of Michigan
Committee on the Use and Care of Animals. Adult male
Sprague–Dawley rats (Harlan, Indianapolis, IN, USA) weighing
200–220 g were kept in individual cages with 12 h light/dark
cycles and were given food and water ad libitum. Intestinal
inflammation was induced by 0.5 mL enemas of TNBS solution
at a dose of 30 mg in 50% ethanol. Control animals were given
0.5 mL enemas of 50% ethanol. Animals were killed humanely
1 week after enemas. Colonic weight and length were measured
as indicators of colitis. Macroscopic assessment of the colitis
severity was scored as follows: 0, no ulcer and no inflammation;
1, local hyperaemia without ulceration; 2, ulceration without
hyperaemia; 3, ulceration and inflammation at one site only;
4, two or more sites of ulceration and inflammation; and
5, ulceration extending more than 2 cm. Histological changes
were graded as follows: 0, no sign of inflammation; 1, very low
level of leucocyte infiltration; 2, low level of leucocyte infiltra-
tion; 3, high level of leucocyte infiltration, high vascular density,
and thickening of the colon wall; and 4, transmural infiltration,
loss of goblet cells, high vascular density, and thickening of the
colon wall.
The brainstem was removed and the medulla oblongata
containing the DMV was sectioned into 400-lm slices at the
interaural level of )4.24 mm to )5.08 mm, according to the atlas
of Paxinos and Watson using a cryostat (Leica CM 1850; Leica
Microsystems, Wetzlar, Germany). Dorsal motor nucleus of the
vagus nuclei were then harvested as described before and total
RNA was extracted using Trizon (Invitrogen).
Immunofluorescent staining Dorsal motor nucleus of the vagus
neurons grown on glass coverslips were fixed with 4% paraformal-
dehyde for 30 min at 4 C, and then permeabilized with 0.1%
saponin in phosphate-buffered saline for 20 min at room tempera-
ture (22 C). To block non-specific binding, cultures were treated
with 10% serum for 30 min at room temperature. Fixed neuronal
cells were incubated with antibodies against PAR-1 and the neuro-
nal marker Hu for 1 h at room temperature, followed by incubation
with Alexa Fluor 594 and FITC conjugated secondary antibodies for
60 min at room temperature. Control staining used IgG.
Data analysis
Results are expressed as mean ± SEM. Data were analysed using
ANOVA and Students t-test as appropriate. Significance was
accepted as P < 0.05.
Techniques for primary cell culture and maintenance, media,
and reagent vendors remained constant throughout all experi-
ments. To exclude any potential contamination by glia cells,
coverslips were superfused with 55 mmol L)1 KCl at the end of
each experiment, and cells were excluded if maximal DF/F0
increment was less than 15%. In this study, n represents the
number of neurons examined. At least four coverslips were used
for each experimental condition.
RESULTS
Activation of PAR-1 and PAR-2 increases [Ca2+]i
in DMV neurons
We have previously described primary culture of DMV
neuronal cells.20 DMV cultures were found to be
composed primarily of neurons with less than one per
cent contamination with glial cells. Less than one
percent of cultured cells were fibroblasts as assessed by
Thy-1 immunostaining. Using in vitro primary DMV
neuronal cell culture, the effects of PAR-1 and PAR-2
activation on the intracellular calcium levels in DMV
neuronal cells were examined. To determine working
concentrations, dose–response curves were generated
using both the physiological agonist (thrombin or tryp-
sin) and the corresponding specific synthetic peptide
(PARP-1 or PARP-2), and the increase in [Ca2+]i was
quantified with respect to basal levels by measuring the
maximal change in DF/F0 (F0 is defined by the average of
fluorescent intensity at the basal level, whereas DF
equals to F1–F0. The results were normalized to 100% of
basal line and expressed as percentage change). All these
experiments were conducted in cultured DMV neurons
only exposed to single dose of individual agonist. Data
were analysed with ANOVA with Bonferroni post tests
comparing each dose to the 10)9 M dose. Statistically
significant difference was denoted as P < 0.05.
Thrombin in a range from 1 nmol L)1 to 1 lmol L)1
produced dose-dependent increments in maximal DF/
F0 (Fig. 1A). Intracellular calcium concentration in-
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creased rapidly after exposure to thrombin, with
calcium levels returning gradually to baseline upon
withdrawal of agonist. A maximum increment in DF/F0
of 229 ± 14% was elicited in DMV neuronal cells by
1 lmol L)1 of thrombin, with a maximum of 89 ± 3%
of cells responding (Fig. 1A). Exposure of cultured
DMV cells to PARP-1 also caused dose-dependent
increases in [Ca2+]i over a concentration range from
1 nmol L)1 to 1 lmol L)1 (Fig. 1B). PARP-1 (1 lmol L)1)
caused increases in DF/F0 of 137 ± 7%, with a maxi-
mum of 87 ± 2% of cells responding.
Treatment of DMV neurons with trypsin caused an
increase in [Ca2+]i, with a maximum DF/F0 of 258 ±
12% at 1 lmol L)1 concentration (Fig. 1C). At
1 lmol L)1 of trypsin, 86 ± 2% of cells responded with
increases in [Ca2+]i. Similar to trypsin, PARP-2
(1 lmol L)1) resulted in a maximum DF/F0 of 242 ±
10% with 83% ± 2% of cultured DMV neuronal cells
demonstrating [Ca2+]i increments (Fig. 1D).
Based on dose–response studies, concentrations of
agonists that exerted a submaximal DF/F0 were chosen
for subsequent experiments. The concentrations of
thrombin and PARP-1 used were 100 nmol L)1 and
100 nmol L)1 respectively. To study PAR-2 activation,
trypsin and PARP-2 concentrations of 100 nmol L)1
were used.
To characterize responsiveness after trypsin and
thrombin exposure, cultured DMV neuronal cells were
repeatedly exposed to these agonists. As shown in
Fig. 2A, repetitive exposure to thrombin produced a
significant decrement in peak DF/F0 responses (n = 69).
Peak DF/F0 for the two exposures was 148 ± 17% and
90 ± 10% respectively. Similar inhibition in peak DF/F0
responses was also observed when cells were exposed
Figure 1 Effect of protease-activated recep-
tors (PARs) activation on [Ca2+]i i in dorsal
motor nucleus of the vagus (DMV) neurons.
(A) Effect of increasing concentrations of
thrombin on the D[Ca2+]i and percentage of
cells responding to the treatment. (B) Effect
of increasing concentrations of PARP-1 on
the D[Ca2+]i and percentage of cells
responding to the treatment. (C) Effect of
increasing concentrations of trypsin on the
D[Ca2+]I and percentage of cells responding to
the treatment. (D) Effect of increasing con-
centrations of PARP2 on the D[Ca2+]i and
percentage of cells responding to the treat-
ment. Values are mean ± SEM.
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to repetitive perfusion of trypsin (Fig. 2B). Peak DF/F0
for the two exposures was 173 ± 21% and 76 ± 9%
respectively.
In the control experiment, subsequent exposure to
thapsigargin (1 lmol L)1) applied at the same intervals
as used in the second application of thrombin induced
an elevation in the intracellular calcium concentration
of an amplitude similar to those elicited by the single
exposure to thapsigargin (peak DF/F0 was 181 ± 15% vs
190 ± 20% respectively, P > 0.05).
Mechanism on PARs-induced [Ca2+]i signalling
The next series of experiments sought to determine the
sources of calcium and signalling pathways responsible
for the increase in intracellular calcium concentration
upon activation of PAR-1 and PAR-2. We firstly deter-
mined whether extracellular stores of Ca2+are involved
in the [Ca2+]i transients. Dorsal motor nucleus of the
vagus cells were perfused with thrombin or trypsin in a
Ca2+-free buffer. As shown in Fig. 3A,B, both thrombin
and trypsin increased intracellular calcium levels in
absence of extracellular calcium, consistent with
release from internal stores.
We next examined the effects of PLC inhibition on
[Ca2+]i elicited by activation of PAR-1 and PAR-2. To
inhibit PLC activity, the aminosteroid U73122
(1 lmol L)1) was added 60 s prior to the perfusion
buffer before addition of the corresponding agonist
peptide. This compound has been shown to inhibit
PLC activity in a variety of cell types. As a negative
control, U73343 (1 lmol L)1), an inactive analogue of
U73122, was used 60 s prior to exposure to agonist.
Neither U73122 nor U73343 alone demonstrated any
effect on baseline [Ca2+]i in cultured DMV neurons
(DF/F0 of 1 ± 0.2% for U73122 and 1.5 ± 0.3% for
U73343 relative to 1.6 ± 0.4% for control, P > 0.05).
Pretreatment DMV neurons with U73122 signifi-
cantly attenuated the thrombin-induced increases in
maximal DF/F0, while U73343 did not demonstrate
any effect (Fig. 4A). Thrombin-mediated increases in
peak DF/F0 were significantly attenuated by pretreat-
ment with U73122 from 140 ± 17% to 21 ± 3%
(P < 0.05) (Fig. 4A). Exposure of DMV neuronal cells
to 1 lmol L)1 U73122 also significantly decreased
trypsin-mediated increment in peak DF/F0 from
185 ± 21% to 19 ± 6% (P < 0.05), while U73343 did
not have any significant effect (148 ± 5% vs
158 ± 5% for control, P > 0.05) (Fig. 4B).
Figure 2 Receptor desensitization caused by initial activation with
thrombin (100 nmol L)1) (A) or trypsin (100 nmol L)1) (B), and sub-
sequent exposure to thrombin (100 nmol L)1) or trypsin
(100 nmol L)1) respectively.
Figure 3 Exposure of cultured dorsal motor nucleus of the vagus
(DMV) neurons to 100 nmol L)1 of thrombin (A) or trypsin (B) in a
Ca2+-free buffer produced a transient increase in [Ca2+]i.
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Phospholipase C has been well characterized to
catalize the production of IP3, which in turn activates
the IP3 receptor on the endoplasmic reticulum to
mobilize the release of calcium from the intracellular
calcium stores. To determine whether activation of
PAR-1 or PAR-2 leads to the release of IP3 sensitive
intracellular calcium stores, we used 2APB to inhibit
IP3 receptor in cultured DMV neurons. 2APB alone did
not alter baseline [Ca2+]i (DF/F0 of 1.4 ± 0.3%, P > 0.05).
Pretreatment of DMV neurons significantly inhibited
the peak DF/F0 responses induced by thrombin (an
inhibition of 72 ± 13%, P < 0.05) (Fig. 5A). Similar to
these observation, either trypsin-induced increases in
maximal increment of DF/F0 were significantly
decreased by 71 ± 10% (P < 0.05) when DMV cells
were pre-exposed to 2APB (Fig. 5B).
Presence of PAR1 and PAR2 in DMV
RT-PCR was performed using primers specific for the
PAR-1 or PAR-2 for DMV tissues from rats. The pres-
ence of transcripts for PAR-1 and PAR-2 in the rat
dorsal motor nucleus was demonstrated in Fig. 6.
Sequence analysis confirmed that these PCR products
match the published sequences for rat PAR1 and PAR2.
Negative control detected no signal. The transcripts for
PAR-1 or PAR-2 were demonstrated to be significantly
elevated in DMV tissues derived from the rats with
IBD as compared to the control animals (Fig. 6). Double
immunofluorescent staining using specific antibodies
against PAR1 and Hu, a neuronal marker, demon-
strated the co-localization of PAR1 and Hu in cultured
DMV neurons, suggesting the expression of PAR
receptor in DMV neuronal cells (Fig. 6C). Negative
control using control IgG detected no signal.
DISCUSSION
Our study demonstrates the presence of functionally
active PAR-1 and PAR-2 in DMV neuronal cells. Five
distinct observations support this conclusion: (i) DMV
neuronal cells respond dose-dependently with incre-
ments in [Ca2+]i to both thrombin and trypsin; (ii)
Dose-dependent increases in [Ca2+]i and in the percent-
age of cells responding were observed with exposure to
synthetic PARP-1 and PARP-2; (iii) Receptor desensi-
Figure 4 Effect of PLC inhibition on [Ca2+]i signalling. Dorsal motor
nucleus of the vagus (DMV) neuronss were exposed to the PLC
inhibitor U73122 (1 lmol L)1) or its inactive analogue U73122
(1 lmol L)1) 1 min before treatment with 100 nmol L)1 of thrombin
(A) or trypsin (B).
Figure 5 Involvement of IP3 sensitive calcium store. Treatment of
cultured dorsal motor nucleus of the vagus (DMV) neurons with the
cell-permeant IP3 receptor inhibitor 2APB (100 lmol L)1) reduced the
[Ca2+]i responses to thrombin (100 nmol L
)1) or trypsin (100 nmol L)1).
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tization typical of PARs was noted with repetitive
exposure; (iv) Activation of PAR-1 or PAR-2 leads to
the mobilization of IP3 sensitive intracellular calcium
store by a mechanism involving PLC; (v) Transcripts
for PAR1 or PAR2 receptors are present in the rat DMV
tissues.
Inflammatory bowel disease is histologically char-
acterized by the infiltration of a large number of
neutrophils, macrophages, lymphocytes and mast
cells in the mucosa and submucosa of intestine, in
particular the large intestine. The infiltration of these
immune cells, as in TNBS-induced colitis activated
CD4 helper T cell, promote an exaggerated autoim-
mune activation, giving rise to a prolonged severe
transmural inflamed intestinal mucosa, characterized
by uncontrolled production of inflammatory cyto-
kines and chemokines.21 These inflammatory cyto-
kines and chemokines have been proposed to
contribute to the changes in neurochemical coding
and the hyperexcitability of the enteric neurons,
accounting for the inappropriate sensing and motility
of the gastrointestinal tract due to IBD. Our findings
extend these observations to include the DMV neu-
rons and challenge the classical notion that DMV is a
well protected nucleus and inert to change. Several
recent studies also support the idea that DMV may be
subject to systemic stimulation. The DMV directly
responds to systemic endotoxin,13 suggesting that the
DMV may possess the characteristics of a circumven-
tricular organ, which may be devoid of a blood–brain
barrier.14–16 In addition, dendrites from neurons of the
DVC have been observed to penetrate the ependymal
layer and enter the floor of the fourth ventricle,
suggesting that the DMV may monitor either the
blood or ventricular fluids.22,23 Furthermore, increase
in permeability through the blood-brain barrier has
been reported in TNBS-induced colitis rats and
rabbits.17,18 Moreover, specific saturable transport
systems for the entry of both TNF-a and IL-1b into
the CNS have been described.24,25 Thus, it is possible
that the DMV is exposed to pro-inflammatory cyto-
kines circulating in blood, particularly in the setting
of acute intestinal inflammation, potentially contrib-
uting to changes in gastrointestinal functions such as
motility. Our previous studies suggest the structural
change in DMV neurons following TNBS-induced
colitis, likely due to the apoptosis caused by the
systemic cytokines such as TNF1a and IL1b.19 Our
current observations demonstrate the presence of
PAR-1 and PAR-2 in the DMV neurons, suggesting
that proteases such as thrombin and trypsin may have
an impact on DMV neurons during intestinal inflam-
mation. As neither thrombin nor trypsin transcripts
were detected in the DMV tissues (data not shown), it
is most likely that the agonists responsive for activa-
tion of PARs in DMV derive from the circulation
which carries the PAR agonists from the inflamma-
tory intestine. However, the probability that vagal




Figure 6 Expression of protease-activated receptor 1 (PAR-1) and PAR-2
mRNA. mRNA levels of PAR-1 (A) and PAR2 (B) in the dorsal motor
nucleus of the vagus (DMV) tissues derived from control or TNBS-in-
duced IBD rats were examined by real time RT-PCR as described in the
text. Data was expressed as mean ± SEM. * indicates P < 0.05 vs. con-
trol. n = 10 for each group. Double immunofluorescent staining using
specific antibodies against PAR1 and Hu, a neuronal marker, demon-
strated the co-localization of PAR1 and Hu in cultured DMV neurons
(C). Negative control using control IgG detected no signal.
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circulating inflammatory mediators and will thus
affect DMV neurons and the vagal efferent outflow
can not be ruled out.
Activation of both PAR-1 and PAR-2 has been
reported to increase [Ca2+]i in different cell types,
through G-protein-mediated activation of different
calcium signalling cascades.10,12,26,27 The intracellular
origin of the initial calcium increase has been demon-
strated in epithelial cell, myenteric neurons and glial
cells, where activation of these receptors induces
increased [Ca2+]i in the absence of extracellular cal-
cium.10,12,28 The specificity of agonist peptides PARP-1
and PARP-2 has been demonstrated in different mod-
els, mimicking thrombin and trypsin actions respec-
tively.10,29–31 PARs demonstrate a unique mechanism
of receptor activation through cleavage of the
N-terminus. This receptor cleavage is believed to
contribute to receptor desensitization, making the
cleaved receptor molecule non-responsive to a second
exposure to protease. This desensitization has been
noted in previous reports in which primary exposure to
trypsin or thrombin abolished subsequent responsive-
ness to the proteases. In contrast, primary exposure to
PARP-1 or PARP-2 results in diminished, but still
present, responsiveness to repetitive exposure to the
synthetic peptides.28,32 Study of PAR-1 and PAR-2
signalling in DMV neuronal cells indicates that recep-
tor activation may lead to rapid release of calcium from
intracellular stores, followed by secondary influx of
calcium from extracellular sources. Moreover, the
current investigation indicates that IP3 is the cellular
intermediate that participates in PAR-1 and PAR-2
calcium signalling in DMV neurons. PAR-1-induced
Ca2+transients were significantly diminished by PLC
inhibition and the IP3 receptor antagonism. These
observations are consistent with previous studies in
which PARs have been reported to couple to PLC,
stimulating IP3 production, and release of calcium
from IP3-sensitive intracellular stores.10,12,28,33
The physiological and pathological role of PAR
signalling in DMV neurons is currently unknown. The
recent finding of a thrombin-generating system in the
brain and the presence of PAR-1 in neurons and glia
suggest that PAR-1 may have functions in addition to
revascularization.34 PAR-2 activation has been related
to release of proteinases in inflammatory and allergic
conditions, vasodilatation of cerebral arteries, release of
prostaglandins, and regulation of cytokine production in
enterocytes.35,36 Mobilization of intracellular calcium
stores upon activation of PARs in DMV neurons
suggests that PARs may play an important role in the
physiological functions of DMV neurons and their
pathological responses to systemic inflammation.
Whether the intracellular calcium signalling induced
by PAR activation in DMV neurons affects the secretion
of neuronal transmitters or contributes to mitochondria-
mediated apoptosis as observed during inflammation
requires further investigation. The effects of intestinal
inflammation include injury to the local cells located in
the intestinal wall and the systemic inflammatory
responsiveness such as anorexia, diarrhoea, and weight
loss. It is likely that intestinal inflammation affects the
structure and function of the DMV, potentially contrib-
uting to the pathophysiology of IBD. Our study suggests
that circulating inflammatory mediators such as throm-
bin released as a consequence of inflammatory bowel
disease affect DMV neurons innervating gastrointesti-
nal organs such as the stomach and intestine. Whether
this effect accounts for the high reported incidence of
gastritis and gastric/duodenal lesions in patients with
IBD is an interesting area remaining to be explored.
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